Answers are grounded in this paper and cite their sources.
This study investigates the anti-inflammatory, fibrinolytic and anti-oxidant activities of the n-hexane extract and fractions of Ficus sur Forssk leaves. The extract was separated on column chromatography using a gradient elution of hexane, dichloromethane and ethanol. Pooled column fractions were assayed for membrane stabilizing for anti-inflammatory, Streptokinase inhibition for fibrinolytic and 2, 2-diphenyl-1-picrylhydrazyl (DPPH) reduction for anti-oxidant activity. Column fractions were pooled into five fractions (F1 – F5). The n-hexane crude extract and the fraction F3 consistently exhibited anti-inflammatory and fibrinolytic ability. The leaf extract of F. sur showed negligible anti-oxidant activity. Except for F1 all the fractions and the crude extract showed very high dose-dependent anti-inflammatory property even significantly higher (p <0.05) than the reference drug – diclofenac. Crude extract, F2 and F3 exhibited fibrinolytic ability. F1 showed the lowest assayed biological activity consistently. The study shows that the column fractions of n-hexane extract of F. sur leaves have fibrinolytic and anti-inflammatory activity and can be used in the management of thrombosis and inflammation.
No takes yet. Share an insight, caveat, or question.
Suleiman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: